Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield health care technology firm, has announced the launch of the multi-center Clinical Utility and Economic (CLUE) Trial. The trial aims to quantify the frequency with which surgeons alter their original treatment plans after receiving data from Aclarion’s proprietary Nociscan technology. In the CLUE Trial, surgeons will determine their…